Skip to main content
James F Rooney

James F Rooney

Forum Advisory Group member since 2006
Vice President, Medical Affairs, Gilead Sciences
San Francisco, United States

James F Rooney joined Gilead Sciences in 1996 as Vice President of Clinical Research and, in 2004, became Vice President of Medical Affairs. From 2004 to 2006, he was also Vice President of Drug Safety and Public Health. James Rooney has been instrumental in the clinical development of the company's antiviral therapies, including for HIV, hepatitis B and C, influenza and COVID-19. Dr Rooney also leads many of the company's clinical research activities in low- and middle-income countries.

Previously, Dr Rooney worked as a global project leader in HIV at Burroughs Wellcome and Glaxo Wellcome. He received his undergraduate degree at Harvard University in Cambridge, Massachusetts, his medical degree and residency training in internal medicine at the University of Maryland Hospital in Baltimore, Maryland, and his training in infectious diseases at the Laboratory of Clinical Investigation, National Institutes of Health, Bethesda, Maryland. Dr Rooney is board certified in Internal Medicine and Infectious Diseases and is a Fellow of the Infectious Diseases Society of America.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.